ACHIEVE LIFE SCIENCES, INC. Business Finance Contracts & Agreements
58 Contracts & Agreements
- Credit Agreements (3 contracts)
- Investment Agreements (1)
- Loan Agreements (1)
- Purchase Agreements (10)
- Registration Rights Agreements (4)
- Release Agreements (1)
- Stock Agreements (8)
- Subscription Agreements (3)
- Underwriting Agreements (9)
- Warrant Agreements (18)
- Securities Purchase Agreement, dated as of May 25, 2023, by and among Achieve Life Sciences, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on May 25, 2023)
- Form of Common Stock Purchase Warrant (Filed With SEC on November 18, 2022)
- Form of Subscription Agreement (Filed With SEC on November 18, 2022)
- Form of Registration Rights Agreement (Filed With SEC on November 18, 2022)
- Loan and Security Agreement, dated April 26, 2022, among Achieve Life Sciences, Inc. and Silicon Valley Bank (Filed With SEC on April 27, 2022)
- First Amendment to 2021 Contingent Convertible Debt Agreement dated December 22, 2021 by and among Achieve Life Sciences, Inc., Silicon Valley Bank, and SVB Innovation Credit Fund... (Filed With SEC on April 27, 2022)
- Contingent Convertible Debt Agreement, dated December 22, 2021, among Achieve Life Sciences, Inc., Silicon Valley Bank and SVB Innovation Credit Fund VIII, L.P (Filed With SEC on December 22, 2021)
- Registration Rights Agreement, dated December 22, 2021, among Achieve Life Sciences, Inc., Silicon Valley Bank and SVB Innovation Credit Fund VIII, L.P (Filed With SEC on December 22, 2021)
- Underwriting Agreement dated May 25, 2021 (Filed With SEC on May 25, 2021)
- Form of Underwriting Agreement (Filed With SEC on November 30, 2020)
- Form of Underwriters Warrant (Filed With SEC on November 30, 2020)
- Underwriting Agreement dated August 3, 2020 (Filed With SEC on August 5, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on August 5, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on April 30, 2020)
- Placement Agent Agreement dated as of April 19, 2020, by and between Achieve Life Sciences, Inc. and Paulson Investment Company, LLC (Filed With SEC on April 30, 2020)
- Form of Subscription Agreement (Filed With SEC on April 30, 2020)
- Form of Registration Rights Agreement (Filed With SEC on April 30, 2020)
- Amendment No. 1 to Purchase Agreement, by and between Achieve Life Sciences, Inc. and Lincoln Park Capital Fund, LLC. dated as of September 14, 2017 (Filed With SEC on March 13, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on December 20, 2019)
- Form of Preferred Stock Certificate (Filed With SEC on December 20, 2019)
- Underwriting Agreement dated as of December 17, 2019, by and between Achieve Life Sciences, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on December 20, 2019)
- Form of Warrant Offered Hereby (Filed With SEC on December 16, 2019)
- Form of Underwriting Agreement (Filed With SEC on December 16, 2019)
- Form of Underwriting Agreement (Filed With SEC on December 2, 2019)
- Common Stock Purchase Warrant, dated as of May 30, 2019 (Filed With SEC on June 3, 2019)
- Warrant Exercise Agreement, dated as of May 30, 2019, by and between Achieve Life Sciences, Inc. and Armistice Capital Master Fund, Ltd (Filed With SEC on June 3, 2019)
- Form of Warrant (Filed With SEC on October 1, 2018)
- Securities Purchase Agreement, dated as of October 1, 2018, by and among Achieve Life Sciences, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on October 1, 2018)
- Underwriting Agreement dated as of June 15, 2018, by and between Achieve Life Sciences, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on June 20, 2018)
- Form of Common Stock Purchase Warrant (Filed With SEC on June 20, 2018)
- Form of Preferred Stock Certificate (Filed With SEC on June 20, 2018)
- Form of Achieve Life Sciences Stock Option Agreement (Filed With SEC on March 1, 2018)
- Form of Achieve Life Sciences Restricted Stock Unit Agreement (Filed With SEC on March 1, 2018)
- Form of Warrant (Filed With SEC on September 14, 2017)
- Purchase Agreement, dated as of September 14, 2017, by and between Achieve Life Sciences, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 14, 2017)
- ONCOGENEX PHARMACEUTICALS INC. SERIES A-1 WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on April 30, 2015)
- PURCHASE AGREEMENT (Filed With SEC on April 30, 2015)
- OncoGenex Pharmaceuticals, Inc. 5,559,866 Shares Pre-Funded Warrants to Purchase 1,340,538 Shares Warrants to Purchase 3,450,202 Shares Common Stock ($0.001par value) Underwriting... (Filed With SEC on June 27, 2014)
- ONCOGENEX PHARMACEUTICALS INC. SERIES A WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on June 27, 2014)
- ONCOGENEX PHARMACEUTICALS INC. PRE-FUNDED SERIES B WARRANT TO PURCHASECOMMON STOCK (Filed With SEC on June 27, 2014)
